RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Stephen P. Saville to Mice, Inbred BALB C

This is a "connection" page, showing publications Stephen P. Saville has written about Mice, Inbred BALB C.
Connection Strength

0.502
  1. Cleary IA, Lazzell AL, Monteagudo C, Thomas DP, Saville SP. BRG1 and NRG1 form a novel feedback circuit regulating Candida albicans hypha formation and virulence. Mol Microbiol. 2012 Aug; 85(3):557-73.
    View in: PubMed
    Score: 0.095
  2. Cleary IA, Reinhard SM, Miller CL, Murdoch C, Thornhill MH, Lazzell AL, Monteagudo C, Thomas DP, Saville SP. Candida albicans adhesin Als3p is dispensable for virulence in the mouse model of disseminated candidiasis. Microbiology (Reading). 2011 Jun; 157(Pt 6):1806-1815.
    View in: PubMed
    Score: 0.087
  3. Cleary IA, Mulabagal P, Reinhard SM, Yadev NP, Murdoch C, Thornhill MH, Lazzell AL, Monteagudo C, Thomas DP, Saville SP. Pseudohyphal regulation by the transcription factor Rfg1p in Candida albicans. Eukaryot Cell. 2010 Sep; 9(9):1363-73.
    View in: PubMed
    Score: 0.083
  4. Saville SP, Lazzell AL, Chaturvedi AK, Monteagudo C, Lopez-Ribot JL. Use of a genetically engineered strain to evaluate the pathogenic potential of yeast cell and filamentous forms during Candida albicans systemic infection in immunodeficient mice. Infect Immun. 2008 Jan; 76(1):97-102.
    View in: PubMed
    Score: 0.069
  5. Saville SP, Lazzell AL, Bryant AP, Fretzen A, Monreal A, Solberg EO, Monteagudo C, Lopez-Ribot JL, Milne GT. Inhibition of filamentation can be used to treat disseminated candidiasis. Antimicrob Agents Chemother. 2006 Oct; 50(10):3312-6.
    View in: PubMed
    Score: 0.064
  6. Saville SP, Lazzell AL, Monteagudo C, Lopez-Ribot JL. Engineered control of cell morphology in vivo reveals distinct roles for yeast and filamentous forms of Candida albicans during infection. Eukaryot Cell. 2003 Oct; 2(5):1053-60.
    View in: PubMed
    Score: 0.052
  7. Romo JA, Pierce CG, Chaturvedi AK, Lazzell AL, McHardy SF, Saville SP, Lopez-Ribot JL. Development of Anti-Virulence Approaches for Candidiasis via a Novel Series of Small-Molecule Inhibitors of Candida albicans Filamentation. mBio. 2017 Dec 05; 8(6).
    View in: PubMed
    Score: 0.035
  8. Thomas DP, Viudes A, Monteagudo C, Lazzell AL, Saville SP, L?pez-Ribot JL. A proteomic-based approach for the identification of Candida albicans protein components present in a subunit vaccine that protects against disseminated candidiasis. Proteomics. 2006 Nov; 6(22):6033-41.
    View in: PubMed
    Score: 0.016
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support